Browse studies

Find your next paid study

27,273 recruiting studies available now

Unmasking Diabetes in Dialysis With Continuous Glucose Monitoring

This study will evaluate whether Continuous Glucose Monitoring (CGM) can identify previously unrecognized diabetes and clinically significant hyperglycemia in …

End Stage Kidney Disease (ESKD)HyperglycaemiaDiabetes

Estimated

~$10 – $750

Actual pay is set by the research site.

Emory UniversityNCT07880795

Phase 1

A Phase I/II Open-label Study of DJI136, a DLL3-targeted CAR-T Therapy, in Adult Patients With ES-SCLC

This is a Phase I/II, open-label, non-randomized, multi-center study in patients with extensive-stage small cell lung cancer (ES-SCLC) to determine the recomme…

Extensive-stage Small Cell Lung Cancer (ES-SCLC)

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Novartis PharmaceuticalsNCT07564401

Phase 2

A Randomized Phase 2/3 Study Evaluating the Safety and Efficacy of Pivekimab Sunirine (PVEK) in Combination With Venetoclax and Azacitidine in Adult Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML) Ineligible to Receive Intensive Chemotherapy

Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. Acute myeloid leukemia (AML) is a cancer of the blood and b…

Acute Myeloid Leukemia

Estimated

~$75 – $3,000

Actual pay is set by the research site.

AbbVieNCT07581002

Repeatable Evaluation of Functional Intra-procedural Signals for Effect in Pulsed Field Ablation. REFINE-PFA

The study is a prospective, exploratory observational study with the ECGenius® System and the PFAnalyzer software module in PFA cases using the FaraPulse PFA s…

Atrial Fibrillation

Estimated

~$10 – $1,125

Actual pay is set by the research site.

CathVision ApSNCT07275151

Phase 3

Metformin (Dimethylbiguanide) and Insulin Resistance in Women Completing Neoadjuvant and/or Adjuvant Cytotoxic Treatment of Stage I-III Breast Cancer

This phase III trial evaluates how often women develop insulin resistance and type-2 diabetes and compares metformin with usual care to usual care alone in tre…

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+1 more

Estimated

~$50 – $1,500

Actual pay is set by the research site.

City of Hope Medical CenterNCT06763328

Phase 3

An Extension Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig, Including Inhaled Corticosteroid Withdrawal, in Adults With Chronic Obstructive Pulmonary Disease (COPD) Who Completed Studies EFC18243 or EFC18244

This is an open-label, Phase 3, long-term safety extension study including participants of previous lunsekimig clinical trials with inadequately controlled chr…

Chronic Obstructive Pulmonary Disease

Estimated

~$50 – $2,250

Actual pay is set by the research site.

SanofiNCT07793409

Phase 1

An Open Label, First-in-human Study of BAY 2927088 in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) Harboring an EGFR and/or HER2 Mutation

Researchers are looking for a better way to treat people who have advanced non-small cell lung cancer (NSCLC), a group of lung cancers that have spread to near…

Advanced Non-small Cell Lung CancerEGFR MutationHER2 Mutation

Estimated

~$150 – $4,500

Actual pay is set by the research site.

BayerNCT05099172

A Descriptive Analysis of the Physiological and Behavioral Profiles of Elite Female Athletes

In May 2026, the Gatorade Brand launched the "Body of Science" (BoS), a multi-year research initiative aimed at closing the gender gap in sports science. While…

Female AthletesHealthy Women

Estimated

~$10 – $1,125

Actual pay is set by the research site.

PepsiCo Global R&DNCT07883278

Phase 2

DURVA+ : Evaluation of the Safety and Pharmacodynamics of Anti-PD-L1 Antibody Durvalumab in Combination With Chemotherapy in Patients With Advanced Solid Tumors

This phase II trial studies the side effects of durvalumab when given together with chemotherapy in treating patients with solid tumors that have spread to oth…

Locally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT03907475

Phase 1

A Randomized, Open Label, Parallel Group Phase 1 Study to Compare Safety, Tolerability and Pharmacokinetics of Subcutaneously Administered MK-1406 as Three Injections Compared With Two Injections in Healthy Adult Participants

The purpose of this trial is to compare what happens to MK-1406 in the body of healthy participants when it is given as 2-injections and 3-injections. Research…

Healthy

Estimated

~$500 – $10,500

Actual pay is set by the research site.

Merck Sharp & Dohme LLCNCT07743151

Phase 3

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of CPL-01 in the Management of Postoperative Pain After Unilateral Distal First Metatarsal Bunionectomy With Osteotomy

Patients with a bunion will have that repaired and then pain and rescue medicine use will be evaluated.

Postoperative PainBunion

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Cali Pharmaceuticals LLCNCT07490496

Observational

A Single-center Randomized Controlled Trial Evaluating Whether Adding Fundal Mucosal Ablation (FMA) to Standard Endoscopic Sleeve Gastroplasty (ESG) Leads to Greater Weight Loss, Improved Obesity-related Comorbidities, and Better Metabolic and Hormonal Outcomes Compared With ESG Alone in Adults With Obesity.

The ENLIGHT Trial is a single-center, randomized controlled trial evaluating whether adding fundal mucosal ablation (FMA) to endoscopic sleeve gastroplasty (ES…

ObesityObesity (Body Mass Index >30 kg/m2)

Estimated

~$10 – $750

Actual pay is set by the research site.

West Virginia UniversityNCT07792226